Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
LODALIS BAUSCH HEALTH, CANADA INC. Actual shortage 625MG Updated Report 2024-05-15 226788
GD-DICLOFENAC/MISOPROSTOL 50 GENMED A DIVISION OF PFIZER CANADA ULC Anticipated shortage 200MCG 50MG Updated Report 2024-05-15 220932
PROZAC CAPSULES 10MG ELI LILLY CANADA INC Anticipated shortage 10MG Updated Report 2024-05-15 220045
GD-DICLOFENAC/MISOPROSTOL 75 GENMED A DIVISION OF PFIZER CANADA ULC Anticipated shortage 200MCG 75MG Updated Report 2024-05-15 227003
APO-WARFARIN APOTEX INC Resolved 1MG Updated Report 2024-05-15 225782
APO-WARFARIN APOTEX INC Resolved 1MG Updated Report 2024-05-15 224589
MYOVIEW 30ML GE HEALTHCARE CANADA INC Actual shortage 1.38MG Updated Report 2024-05-15 226858
METHOTREXATE INJECTION USP PFIZER CANADA ULC Anticipated shortage 25MG New Report 2024-05-15 228024
MYLAN-TOPIRAMATE MYLAN PHARMACEUTICALS ULC Resolved 100MG Updated Report 2024-05-15 224061
MYLAN-VALACYCLOVIR MYLAN PHARMACEUTICALS ULC Resolved 500MG Updated Report 2024-05-15 223279

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
EYE STREAM ALCON CANADA INC Discontinued 0.03% 0.048% 0.075% 0.64% New Report 2024-05-15 228021
MYLAN-NITRO SUBLINGUAL SPRAY MYLAN PHARMACEUTICALS ULC Discontinued 0.4MG New Report 2024-05-08 227338
CHAMPIX PFIZER CANADA ULC Discontinued 1MG 0.5MG New Report 2024-05-03 227052
CHAMPIX PFIZER CANADA ULC Discontinued 1MG New Report 2024-05-03 227049
CHAMPIX PFIZER CANADA ULC Discontinued 0.5MG New Report 2024-05-03 227046